ART and Ferndale Labs Enter into Commercial Deal in August 2015
08-14-2015
more details

Mastisol Plus Bacitracin Product Receives Exemption From FDA
01-06-2015
more details

Good News for Jaleva’s ‘Mast-R-Prep’ Market Research Results
04-02-2013
more details

Jaleva Announces Preclinical PK Test Results for ‘RelievaDrop’ Transbuccal Alprazolam and ‘RelievaDrop’ Transbuccal Ondansetron
11-21-2011
more details

Jaleva Confirms Regulatory Route for RelievaDrop Nicotine Replacement Therapy Product
10-08-2011
more details

Jaleva’s ‘Nicofix’, a Transbuccal Nicotine Replacement Therapy Product, Announces 2nd Round of Outstanding Test Results
02-22-2011
more details

Jaleva’s ‘Nicofix’, a Transbuccal Nicotine Replacement Therapy Product, achieves outstanding test results
02-22-2011
more details

Jaleva’s transmucosal Nicotine Replacement Therapy (NRT) product formulation is finalized and is currently in active development. Clinical & pre-clinical trials scheduled.
09-10-2010
more details

FDA confirms 505b2 regulatory route for Jaleva’s licensed prep product, achieving a major contractual milestone.
07-16-2010
more details

Jaleva’s ‘Mast-R-Prep’, a one-step surgical skin prep product achieves outstanding in vivo test results.
09-15-2008
more details

Jaleva’s ‘Mast-R-Prep’, a one-step surgical skin prep product achieves outstanding time kill & mic test results.
06-02-2008
more details

Good news for Jaleva’s‘Mast-R-Prep’ surgical skin prep market research.
06-02-2008
more details

Jaleva signs licence agreement with well-established mid-west US pharmaceutical company for its Stayzon product.
07-06-2007
more details